Viridian Therapeutics, Inc./DE Property, Plant and Equipment, Gross
Viridian Therapeutics, Inc./DE (VRDN) had Property, Plant and Equipment, Gross of $2.44 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-02-26
- 2025-12-31: Property, Plant and Equipment, Gross $2.44M.
- 2024-12-31: Property, Plant and Equipment, Gross $2.50M.
- 2023-12-31: Property, Plant and Equipment, Gross $2.72M.
- 2022-12-31: Property, Plant and Equipment, Gross $3.33M.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2025-12-31 | $2.44M 10-K · filed 2026-02-26 | |
| 2024-12-31 | $2.50M 10-K · filed 2026-02-26 | |
| 2023-12-31 | $2.72M 10-K · filed 2025-03-03 | |
| 2022-12-31 | $3.33M 10-K · filed 2024-02-27 | |
| 2021-12-31 | $2.15M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $2.12M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $2.05M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $1.91M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $3.75M 10-K · filed 2022-03-11 | |
| 2020-09-30 | $3.84M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $3.81M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $3.82M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $3.87M 10-K · filed 2021-03-26 | |
| 2019-09-30 | $3.89M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $3.87M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $3.85M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $3.82M 10-K · filed 2020-03-13 | |
| 2018-09-30 | $3.77M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $3.56M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $3.47M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $3.40M 10-K · filed 2019-03-14 | |
| 2017-09-30 | $3.39M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $3.32M 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $3.22M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $3.18M 10-K · filed 2018-03-15 | |
| 2016-09-30 | $1.90M 10-Q · filed 2016-10-26 | |
| 2016-06-30 | $1.90M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $1.90M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $1.89M 10-K · filed 2017-03-24 | |
| 2015-09-30 | $1.87M 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $1.84M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $1.81M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $1.77M 10-K · filed 2016-03-21 | |
| 2014-09-30 | $1.34M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $1.34M 10-Q · filed 2014-08-14 | |
| 2013-12-31 | $1.34M 10-K · filed 2015-03-27 | $1.34M 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |